First Look: TSMC Profit Surges 77%, Uber and Eli Lilly Announce Major Deals

The Quick Take

• TSMC reported a 77% surge in Q2 net profit driven by surging AI chip demand from major tech customers
• Eli Lilly is reported to be in advanced acquisition talks for a psychedelic drug developer
• Uber announced a major deal adding to active corporate news flow during earnings season

Thursday morning brought a busy slate of corporate developments, with three headline stories competing for investor attention in pre-market trading. TSMC reported a 77% surge in Q2 net profit driven by relentless demand for advanced semiconductors from AI hardware manufacturers, validating the capex supercycle narrative that has underpinned technology sector valuations through 2026. The result came even as the chipmaker's stock experienced selling pressure from traders taking profits on a well-telegraphed outcome.

Separately, Eli Lilly was reported to be in advanced acquisition talks for a psychedelic drug developer, a move that would extend the pharmaceutical giant's reach into neurological and psychiatric treatment modalities. The potential deal underscores a broader pattern of large-cap pharma using strong cash flows from blockbuster obesity and diabetes drugs to pursue diversification into adjacent therapeutic areas, reflecting both commercial caution about patent cliffs and scientific interest in non-traditional drug pathways.

Uber's deal activity added to a morning of high corporate news flow, with the rideshare and logistics platform continuing to expand its strategic footprint across mobility and delivery services. The clustering of major announcements in a single session reflects the intensity of mid-year corporate calendars during earnings season, when management teams often time strategic disclosures alongside quarterly results to maximise market attention and analyst coverage.

Synthesized from 1 source.